跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CEFIXIMA NECLIFE 100 MG/5 ML POLVO PARA SUSPENSION ORAL EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
CEFIXIMA NECLIFE 100 MG/5 ML POLVO PARA SUSPENSION ORAL EFG
Approved
STANDARD
CEFIXIMA NECLIFE 100 MG/5 ML POLVO PARA SUSPENSION ORAL EFG
Neclife Pt Unipessoal Lda.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Dec 15, 2020
Approval ID
bedf1f6efc4f7f64
Company
Neclife Pt Unipessoal Lda.
Type
Standard
Approval Details
Approval Id
bedf1f6efc4f7f64
Drug Cima Aemps Name
CEFIXIMA NECLIFE 100 MG/5 ML POLVO PARA SUSPENSION ORAL EFG
Register Number
85640
Holder Company Name
Neclife Pt Unipessoal Lda.
Marketing Company Name
Neclife Pt Unipessoal Lda.
Authorization Date
2020-12-15
Dosage Form
POLVO PARA SUSPENSIÓN ORAL
Dose
100 mg/5 ml
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Neclife Pt Unipessoal Lda.
Active Ingredients
CEFIXIMA TRIHIDRATO
111,917 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Dec 15, 2020
Approval ID
bedf1f6efc4f7f64
Type
Standard
Back to CIMA-AEMPS Approvals